Loading clinical trials...

Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP) | Clinical Trials | Clareo Health

COMPLETEDNCT03314207

Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP)

The purpose of this study is to evaluate subjects with X-linked retinitis pigmentosa caused by RPGR-ORF15 mutations in a clinical setting to fully characterize their condition, measure testing variabi...

Lead sponsor: Beacon Therapeutics•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa

NCT07174726 · X-Linked Retinitis Pigmentosa (XLRP)

RECRUITINGPhase 1/2

Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa

NCT06492850 · X-Linked Retinitis Pigmentosa (XLRP)

Active Not RecruitingPhase 2

A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP)

NCT06646289 · X-Linked Retinitis Pigmentosa

Active Not RecruitingPhase 2/3

A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP

NCT04850118 · X-Linked Retinitis Pigmentosa

Active Not RecruitingPhase 1/2

4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)

NCT04517149 · X-Linked Retinitis Pigmentosa

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 11, 2023Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment14

Start dateDec 2017

Last updatedJan 11, 2023

Condition

X-Linked Retinitis Pigmentosa

Locations shown

Duke Eye Center, Duke University Medical Center

Durham, North Carolina

Casey Eye Institute, Oregon Health and Sciences University

Portland, Oregon

Retina Foundation of the Southwest

Dallas, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 11, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions